期刊文献+

复方丹参注射液静点联合降浊灵冲剂治疗慢性肾功能衰竭的临床分析

Clinical Analysis of Compound Salvia Miltiorrhiza Injection Intravenous Combined Jiangzhuo Ling Granule in Treatment of Chronic Renal Failure
下载PDF
导出
摘要 目的分析复方丹参注射液静点联合降浊灵冲剂治疗慢性肾功能衰竭的临床治疗效果。方法将我院2009年3月至2010年3月之间收录的54例慢性肾功能衰竭的患者随机的分为两组,其中对照组患者主要采取常规的西药治疗,而对照组患者除了在原来的常规西药治疗之外还采取复方丹参注射液静点联合降浊灵冲剂进行治疗,观察两组患者的治疗效果。结果通过两组的疗效对比,其中对照组患者的治疗总效率为74.0%,治疗组患者的治疗总效率为92.6%,明显治疗组情况由于对照组的情况,两组的比较具有显著的差异性(P<0.05),有统计学意义。结论复方丹参注射液静点联合降浊灵冲剂治疗慢性肾功能衰竭具有显著的临床效果,值得临床应用推广。 Objective To analysis of compound salvia miltiorrhiza injection intravenous combined Jiangzhuo Ling Granule in treating chronic renal failure treatment.Methods In our hospital from 2009 March to 2010 March included 54 cases of chronic renal failure patients were randomly divided into two groups,in which the patients in the control group adopted conventional western medicine treatment,while control group patients in addition to the original routine western medicine therapy in addition to adopt compound salvia miltiorrhiza injection intravenous combined Jiangzhuo Ling Granule by treatment,two groups were observed in patients with therapeutic effect.Results The two groups of the comparative efficacy of patients in the control group,which treated by total efficiency is 74%,the patients in the treatment group was treated by total efficiency of 92.6%,obvious treatment group by group,two groups comparative has significant difference(P0.05),there was statistical significance.Conclusion Compound Danshen injection intravenous combined Jiangzhuo Ling Granule in treating chronic renal failure with significant clinical effect,it is worthy of clinical application.
作者 张志民
出处 《中国医药指南》 2013年第6期258-259,共2页 Guide of China Medicine
关键词 复方丹参注射液静点 降浊灵冲剂 慢性肾功能衰竭 临床疗效 Compound salvia miltiorrhiza injection intravenously Jiangzhuo Ling Granule Chronic renal failure Clinical efficacy
  • 相关文献

参考文献5

二级参考文献12

  • 1郑其伟 钱淳宜.穴位注射[A]..中国针灸治疗学[C].北京:科学技术出版社,1990.179.
  • 2毕增祺.慢性肾功能衰竭[A]..肾脏病学:第2版[C].北京:人民卫生出版社,2001.1385.
  • 3王振纲 周金黄.黄芪的免疫药理学研究[A]..中药药理与临床研究进展(第1册)[C].北京:中国科学技术出版社,1992.254.
  • 4叶任高.慢性肾衰竭[A]..内科学:第5版[C].北京:人民卫生出版社,2000.569.
  • 5王海燕.肾脏病学(第2版)[M].北京:人民卫生出版社,2001.1385-1395.
  • 6Diplinger H, Lackner C, Kronen berg F, et al. Elerated Plasma Concentrations of Lipoprotein(a) in Patients with End-stage Renal Disease Are Not Related to the Size Polymorphism of Apolipoprotein(a ). J Clin Invest, 1993,91 (2):397.
  • 7Coritsidis G, Rifici V, Gupta S, et al. Perferential binding of oxidized LDL to rat glomeruli invivo and cultured mesangial cells in vitro. Kidney Int, 1991,39: 358.
  • 8Izarno H. Erythrocyte Na, K-ATP ase in uremia. J Clin Invest, 1984,74: 81.
  • 9Spivak JL, et al. Erythropoietin is both a mitogenand a survival factor. Blood, 1991. 1228.
  • 10朱辟疆,江一芳,任春荣,解冰,韦先进,奚华明.保元健肾片对慢性肾功能衰竭脂质代谢紊乱的影响[J].中华肾脏病杂志,1994,10(5):302-303. 被引量:15

共引文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部